Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotic Approvals in the Last Decade: Are We Keeping Up With Resistance?
Elias B. Chahine, John A. Dougherty, Krisy‐Ann Thornby, et al.
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 4, pp. 441-462
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Bacterial persisters: molecular mechanisms and therapeutic development
Hongxia Niu, Jiaying Gu, Ying Zhang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
Ramanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2534-2550
Closed Access | Times Cited: 44
The Use and Impact of Antibiotics in Plant Agriculture: A Review
Özgur Batuman, Kellee Britt-Ugartemendia, Sanju Kunwar, et al.
Phytopathology (2024) Vol. 114, Iss. 5, pp. 885-909
Closed Access | Times Cited: 10
Nanoantibiotics to fight multidrug resistant infections by Gram-positive bacteria: hope or reality?
Francesca Berini, Viviana Teresa Orlandi, Rosalba Gornati, et al.
Biotechnology Advances (2022) Vol. 57, pp. 107948-107948
Open Access | Times Cited: 32
Recovering the susceptibility of antibiotic-resistant bacteria using photooxidative damage
Jennifer M. Soares, Vladislav V. Yakovlev, Kate Cristina Blanco, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 39
Open Access | Times Cited: 16
History of the streptothricin antibiotics and evidence for the neglect of the streptothricin resistome
Ezabelle Franck, Terence S. Crofts
npj Antimicrobials and Resistance (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 6
Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract Library
Lucero Martínez-Fructuoso, S J Ryan Arends, Vítor F. Freire, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 6, pp. 1245-1256
Open Access | Times Cited: 14
A Novel Isotropic Optical Fiber: Antimicrobial Effect of Blue Light on Drug Resistant Organisms
Megan H. Goh, Robert A. Rabiner, Joseph J. Connolly, et al.
Journal of Orthopaedic Research® (2025)
Closed Access
Supramolecular Complexes of Ultrashort Cationic Lipopeptides with Cyclodextrins: Improved Selectivity and Therapeutic Potential
Chiara Bellini, Unai Atxabal, Szilvia Bősze, et al.
Aggregate (2025)
Open Access
An Australian perspective on clinical, economic and regulatory considerations in emerging nanoparticle therapies for infections
Benjamin W. Muir, Jennifer A. E. Payne, Jennifer Martin, et al.
npj Antimicrobials and Resistance (2025) Vol. 3, Iss. 1
Open Access
Recent advance in macrolactams: Structure, bioactivity, and biosynthesis
Jiawei Qiu, Ruiying Qin, Shuai Zhi, et al.
Bioorganic Chemistry (2025), pp. 108406-108406
Closed Access
Cranberry constituents prevent SOS-mediated filamentation of uropathogenic Escherichia coli
Tracy Prinster, Alistair Harrison, Christopher J. Dick, et al.
Infection and Immunity (2025)
Open Access
Implications of two-component systems EnvZ/OmpR and BaeS/BaeR in in vitro temocillin resistance in Escherichia coli
Patricia Pérez‐Palacios, José Luis Rodríguez-Ochoa, Ana Velázquez-Escudero, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 3, pp. 641-647
Open Access | Times Cited: 4
Nationwide Analysis of Antimicrobial Prescription in Korean Hospitals between 2018 and 2021: The 2023 KONAS Report
Ilkoo Yun, Hyo Jung Park, Jungmi Chae, et al.
Infection and Chemotherapy (2024) Vol. 56, Iss. 2, pp. 256-256
Open Access | Times Cited: 4
Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections
Dounia Elfadil, Walid F. Elkhatib, Gharieb S. El‐Sayyad
Microbial Pathogenesis (2022) Vol. 170, pp. 105721-105721
Closed Access | Times Cited: 17
β-Lactams from the Ocean
Jed F. Fisher, Shahriar Mobashery
Marine Drugs (2023) Vol. 21, Iss. 2, pp. 86-86
Open Access | Times Cited: 10
β-Barrel Assembly Machinery (BAM) Complex as Novel Antibacterial Drug Target
Qian Xu, Min Guo, Fei‐Yuan Yu
Molecules (2023) Vol. 28, Iss. 9, pp. 3758-3758
Open Access | Times Cited: 10
Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems
Nadja Blasey, Daria Rehrmann, Anna Katharina Riebisch, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 9
Tobramycin Nanoantibiotics and Their Advantages: A Minireview
Mariella Rosalia, Enrica Chiesa, Erika Maria Tottoli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14080-14080
Open Access | Times Cited: 13
Riboflavin-Vancomycin Conjugate Enables Simultaneous Antibiotic Photo-Release and Photodynamic Killing against Resistant Gram-Positive Pathogens
Bethany Mills, Alex Kiang, Syam Mohan P. C. Mohanan, et al.
JACS Au (2023) Vol. 3, Iss. 11, pp. 3014-3023
Open Access | Times Cited: 7
Antibacterial and Antivirulence Activities of Acetate, Zinc Oxide Nanoparticles, and Vitamin C Against E. coli O157:H7 and P. aeruginosa
Selwan Hamed, Mohamed Emara
Current Microbiology (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 6
Computer-aided drug repurposing to tackle antibiotic resistance based on topological data analysis
Antonio Tarín-Pelló, Beatriz Suay‐García, Jaume Forés-Martos, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107496-107496
Open Access | Times Cited: 5
The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example
Faris S. Alnezary, Masaad Saeed Almutairi, Anne J Gonzales-Luna, et al.
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1441-1441
Open Access | Times Cited: 4
Antibiotic Development: Lessons from the Past and Future Opportunities
Michael S. Kinch, Zachary Kraft, Tyler Schwartz
Pharmaceutical Research (2024) Vol. 41, Iss. 5, pp. 839-848
Closed Access | Times Cited: 1
Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability
André Campaniço, Shrika G. Harjivan, Elisabete B. Freitas, et al.
ChemMedChem (2023) Vol. 18, Iss. 24
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top